3652 results for «383»
3652 results
TAVI procedural complications - Part 6: paravalvular leak, basilica and more
20 May 2026 – From EuroPCR 2026
Delve into complex TAVI procedural complications including paravalvular leak and challenges such as BASILICA technique failures, aortic dissection, valve infolding, and valve dislocation. This session presents real-world cases illustrating troubleshooting strategies and innovative interventions like TAVI-in-TAVI procedures to address these critical scenarios.
Intracoronary imaging insights in ACS
20 May 2026 – From EuroPCR 2026
Discover how intracoronary imaging advances understanding and management of acute coronary syndromes (ACS). This session explores high-definition intravascular ultrasound for PCI guidance, novel predictive metrics, and the impact of emerging factors like microplastics on plaque instability, alongside pathophysiological insights into layered plaques and coronary ectasia in...
New insights in coronary atherosclerosis using intracoronary imaging
21 May 2026 – From EuroPCR 2026
This session provides new insights into coronary atherosclerosis through intracoronary imaging studies. It investigates the relationship between Lp(a) levels and high-risk plaques, characteristics of vulnerable plaques and thrombus in ACS, non-culprit lesion events, lipid core burden in STEMI, and the prognostic value of AI-derived lipid-to-cap ratios,...
From entry to exit: managing arterial access for nurses and allied professionals
20 May 2026 – From EuroPCR 2026
This session focuses on arterial access management tailored for nurses and allied health professionals. It highlights key anatomical landmarks, demonstrates the purpose and use of common vascular closure devices through live manikin demonstrations, and discusses the essential role of nursing and allied staff in vascular access...
Expect the unexpected when treating calcified lesions
20 May 2026 – From EuroPCR 2026
Addressing the unexpected challenges in treating calcified lesions, this session showcases novel combined strategies for managing distal small-vessel coronary perforations, alongside complex case studies involving perforations, dissections, and stent complications related to calcified nodules. It provides valuable insights into rescue techniques and complication management to improve...
Prognostics elements on multivessel disease and coronary artery disease
20 May 2026 – From EuroPCR 2026
This session examines key prognostic elements in multivessel and coronary artery disease, featuring studies on mechanical circulatory support across LDL-C levels, biomarkers impacting periprocedural myocardial infarction, autologous cell therapy outcomes for refractory angina, and novel risk stratification indices. It also addresses prognosis in cancer patients and...
AI adoption in the cathlab of tomorrow - Risk prediction applications
20 May 2026 – From EuroPCR 2026
This session delves into the adoption of artificial intelligence in the cath lab, focusing on clinically useful risk prediction models for coronary and structural interventions. It covers advanced AI-guided intravascular imaging, machine learning applications for adverse event prediction, and critical evaluation of model validation and clinical...
The pearl of unloading with mechanical circulatory support
21 May 2026 – From EuroPCR 2026
Delve into the critical aspects of mechanical circulatory support in cardiogenic shock, focusing on device selection, assessment of persistent congestion, and the application of unloading tools to improve patient management and outcomes.
RIVER: Rivaroxaban for valvular heart disease and atrial fibrillation
05 Sep 2023
Alex Sticchi provides his take on the results of the RIVER trial, which were presented by Pedro Gabriel Barros E Silva during the ESC 2023 congress in Amsterdam.
Rivaroxaban versus Warfarin in Patients with Bioprosthetic Valves According to Valvular Heart Disease Etiology, and Thrombotic and Bleeding Risks: Insights from...
Author
Preventive PCI or medical therapy alone for atherosclerotic coronary vulnerable plaques (PREVENT)
08 Apr 2024
Ali Nazmi Calik provides his take on the results of the PREVENT trial presented at ACC.24 in Atlanta.
Author
The CLEAR SYNERGY (OASIS 9) Trial: A 2x2 factorial randomized controlled trial of colchicine versus placebo and spironolactone versus placebo in patients with myocardial infarction
18 Nov 2024
Mirvat Alasnag provides her take on the CLEAR SYNERGY trial presented by Sanjit S Jolly at AHA 2024 in Chicago.
Author
NOTION-3 - Percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation
01 Sep 2024
Make the most of the insights from Jacob Thomsen Loenborg’s interview with Chiara De Biase and Ali Nazmi Calik’s article to capture the key takeaways from this trial, simultaneously published in the NEJM, presented at the ESC Congress 2024 in London.
Author
Author
Author
